Depletion of DNA Polymerase Theta Inhibits Tumor Growth and Promotes Genome Instability through the cGAS-STING-ISG Pathway in Esophageal Squamous Cell Carcinoma.
Jian LiJosephine Mun-Yee KoWei DaiValen Zhuoyou YuHoi Yan NgJean-Sebastien HoffmannMaria Li LungPublished in: Cancers (2021)
Overexpression of the specialized DNA polymerase theta (POLQ) is frequent in breast, colon and lung cancers and has been correlated with unfavorable clinical outcomes. Here, we aimed to determine the importance and functional role of POLQ in esophageal squamous cell carcinoma (ESCC). Integrated analysis of four RNA-seq datasets showed POLQ was predominantly upregulated in ESCC tumors. High expression of POLQ was also observed in a cohort of 25 Hong Kong ESCC patients and negatively correlated with ESCC patient survival. POLQ knockout (KO) ESCC cells were sensitized to multiple genotoxic agents. Both rH2AX foci staining and the comet assay indicated a higher level of genomic instability in POLQ-depleted cells. Double KO of POLQ and FANCD2, known to promote POLQ recruitment at sites of damage, significantly impaired cell proliferation both in vitro and in vivo, as compared to either single POLQ or FANCD2 KOs. A significantly increased number of micronuclei was observed in POLQ and/or FANCD2 KO ESCC cells. Loss of POLQ and/or FANCD2 also resulted in the activation of cGAS and upregulation of interferon-stimulated genes (ISGs). Our results suggest that high abundance of POLQ in ESCC contributes to the malignant phenotype through genome instability and activation of the cGAS pathway.
Keyphrases
- induced apoptosis
- rna seq
- cell proliferation
- cell cycle arrest
- poor prognosis
- genome wide
- oxidative stress
- single cell
- newly diagnosed
- endoplasmic reticulum stress
- gene expression
- cell free
- cell death
- signaling pathway
- high throughput
- circulating tumor
- ejection fraction
- transcranial magnetic stimulation
- dna methylation
- copy number
- wastewater treatment
- long non coding rna
- single molecule
- prognostic factors
- circulating tumor cells
- antibiotic resistance genes
- prefrontal cortex